Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,584.90
(
-0.60%
)
US TECH 100
23,617.20
(
-0.75%
)
Dow Jones
45,891.66
(
-0.72%
)
Brent Oil
107.41
(
0.77%
)
Bitcoin
69,368.83
(
-2.63%
)
News Focus
News Focus

Replies to post #145768 on Biotech Values

Replies to #145768 on Biotech Values
icon url

DewDiligence

07/19/12 5:47 PM

#145769 RE: masterlongevity #145768

Agreed (eom).
icon url

DewDiligence

07/27/12 7:47 AM

#146095 RE: masterlongevity #145768

GRFS and Octapharma, BAX's competitors in IVIG, are not waiting around to see if Gammagard works for AD in phase-3. Rather, they have started their own AD trials—see #msg-50841315 and #msg-49232696.